Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

35

Revenue 2017

Symbicort

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Symbicort was produced by AstraZeneca and Astellas.

Malcolm's Market Eye, February 01, 2008

A silver lining was presented by AZís cholesterol drug Crestor (rosuvastatin) and asthma treatment Symbicort (budesonide/ formoterol), sales of both rose 21 per cent in the quarter.

Malcolm's Market Eye: 27 October to 2 November 2007

Advair (fluticasone), GSKís best-selling asthma treatment, has been knocked back by AstraZenecaís (AZ) competitor product, Symbicort (budesonide/ formoterol), which has invaded its market.

Friends in high places

In the area of COPD, Symbicort (which has reduced advertising activity compared to 2006) remains top in terms of patient friendliness (47 per cent, unchanged since the first quarter). ... Seretide, Spiriva and Symbicort are all stable in the 'would

The finishing post

Osteoarthritis and rheumatoid arthritis. Canada. Budesonide/Formoterol. Symbicort; AstraZeneca. Asthma. US. Adalimumab.

Malcolm's Market Eye: August 8

Sales of AstraZenecaís five key blockbuster drugs, Symbicort for asthma, Arimidex for cancer, Crestor for cholesterol and Nexium for stomach ulcers, grew by a combined 15 per cent in H1, although

[ Previous 5 results ] 9 10 11 12 13 14 15 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

Empowering the MS patient through shared decision making
Patient advocate Trishna Bharadia explains why shared decision making is crucial for ensuring multiple sclerosis patients feel heard and empowered...
What pharma marketers can learn from Disney
Why we need to continue to innovate, and surprise our audience...
Good data is nothing without advocacy
...

Infographics